Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevance.
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
M M
MM
Patnaik
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
M F
MF
Zahid
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
T L
TL
Lasho
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
C
C
Finke
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
R L
RL
Ketterling
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
N
N
Gangat
Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.
K D
KD
Robertson
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
C A
CA
Hanson
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
A
A
Tefferi
Blood. 2016 May 19;127(20):2391-405
27069254
J Clin Oncol. 2013 Jul 1;31(19):2428-36
23690417
Nature. 2013 Aug 22;500(7463):415-21
23945592
Blood Cancer J. 2015 Jan 02;5:e270
25555161
Blood Cancer J. 2016 Jan 15;6:e385
26771811
N Engl J Med. 2014 Dec 25;371(26):2488-98
25426837
Nat Commun. 2016 Feb 24;7:10767
26908133